Skip to content

Research on intratumoral heterogeneity of diffuse intrinsic pontine gliomas based on stereotactic biopsy

Research on intratumoral heterogeneity of diffuse intrinsic pontine gliomas based on stereotactic biopsy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000034637
Enrollment
Unknown
Registered
2020-07-12
Start date
2020-07-20
Completion date
Unknown
Last updated
2020-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diffuse intrinsic pontine gliomas

Interventions

Case series:Stereotactic biopsy

Sponsors

Beijing Tiantan Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged 2-70 years old; 2. The patient's history and preoperative imaging results support the diagnosis of DIPG; the maximum transverse diameter of the lesion is greater than or equal to 3cm; 3. After clinical comprehensive evaluation, the patient's condition is suitable for stereotactic biopsy, and the patients and their families decide to receive stereotactic biopsy.

Exclusion criteria

Exclusion criteria: 1. Patients with brainstem lesions have undergone radiotherapy, chemotherapy, surgery and other treatments; 2. The patients can not complete the preoperative examination required by stereotactic biopsy, or the patients can not cooperate with the stereotactic biopsy, or the patients have the contraindications such as abnormal coagulation function, serious mental illness, infection of the puncture site and so on; 3. Patients or their family members refuse to participate in the study, or the patients (or their legal guardians) do not sign the informed consent of the study; 4. Other conditions which are considered not suitable to participate in this study by researchers.

Design outcomes

Primary

MeasureTime frame
Pathological examination results;Nucleic acid sequencing results;TCR sequencing results;

Countries

China

Contacts

Public ContactLiwei Zhang

Beijing Tiantan Hospital, Capital Medical University

zhangliweittyy@163.com+86 010-59976514

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026